8 terminated. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Terminated 8 |
Follow Osteoporosis: new trials by email Literature Review of Osteoporosis trials Research Report on Osteoporosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease Denosumab, NaCl (placebo) - Female With Osteoporosis and Chronic Kidney Disease | Phase 4 | Terminated | University Hospital, Montpellier | 4 | 2018-11-19 | 2023-08-09 |
| The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury Denosumab (Prolia), Placebo (normal saline) - Secondary Osteoporosis, Spinal Cord Injury | Phase 4 | Terminated | James J. Peters Veterans Affairs Medical Center | 5 | 2017-04-01 | 2024-03-15 |
| Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss Alendronate, Placebo, calcium carbonate and colecalciferol - Bone Demineralization | Phase 4 | Terminated | University College Dublin | 53 | 2016-05-01 | 2022-05-26 |
| Study About the Effect of Preventive Adjacent Level Cement Augmentation After Osteoporotic Vertebral Compression Fractures Augmentation vertebroplasty, Augmentation and prophylactic vertebroplasty - Osteoporosis, Vertebral Fracture | Phase 4 | Terminated | University of Bern | 100 | 2015-01-01 | 2023-03-16 |
| Bone Microarchitecture in Osteopenic Postmenopausal Women placebo, risedronate - Osteoporosis | Phase 4 | Terminated | Warner Chilcott | 13 | 2008-07-01 | 2013-04-22 |
| The Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral Density ibandronate, teriparatide - Osteoporosis | Phase 4 | Terminated | Papageorgiou General Hospital | 19 | 2006-07-01 | 2014-10-29 |
| ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week Risedronate - Osteoporosis | Phase 4 | Terminated | Sanofi | 7 | 2005-05-01 | 2009-09-25 |
| Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation Risedronate, Raloxifene, Placebo - Osteoporosis, Postmenopausal | Phase 4 | Terminated | Sanofi | 6 | 2004-06-01 | 2011-01-11 |
Acquired Immunodeficiency Syndrome (1) · Bone Demineralization, Pathologic (1) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Fractures, Bone (1) · Osteoporosis, Postmenopausal (1) · Renal Insufficiency, Chronic (1) · Spinal Cord Injuries (1) · Spinal Fractures (1) · Vascular Calcification (1)
Metabolic Diseases (8) · Musculoskeletal Diseases (8) · Nutritional and Metabolic Diseases (8) · Bone Diseases (7) · Bone Diseases, Metabolic (7) · Wounds and Injuries (3) · Urogenital Diseases (2) · Back Injuries (1) · Blood-Borne Infections (1) · Calcinosis (1) · Calcium Metabolism Disorders (1) · Central Nervous System Diseases (1) · Chronic Disease (1) · Communicable Diseases (1) · Disease Attributes (1)
Risedronic Acid (3) · Denosumab (2) · Alendronate (1) · Calcium Carbonate (1) · Cholecalciferol (1) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Ibandronic Acid (1) · Raloxifene Hydrochloride (1) · Saline Solution (1) · Tenofovir (1) · Teriparatide (1)
Sanofi (2) · James J. Peters Veterans Affairs Medical Center (1) · Papageorgiou General Hospital (1) · University College Dublin (1) · University Hospital, Montpellier (1) · University of Bern (1) · Warner Chilcott (1)
United States (3) · Argentina (1) · France (1) · Greece (1) · Ireland (1) · Israel (1) · Switzerland (1)
Ana M Balske, MD, PhD (1) · Efstathios Mitsopoulos, MD (1) · Jean-Marc Chantelot, MD (1) · Patrick WG Mallon, MB BCh BAO,PhD,FRCPI (1) · Paul Heini, MD, professor, head of dept. (1) · Steven C Kirshblum, M.D. (1) · Tara Semanchik (1) · William A Bauman, M.D. (1)